Summit Trail Advisors, LLC Pfizer Inc Transaction History

Summit Trail Advisors, LLC

$3.71 Billion
Q1 2024

A detailed history of Summit Trail Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 58,448 shares of PFE stock, worth $1.64 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

58,448

Previous 44,938 30.06%

Holding current value

$1.64 Million

Previous $1.29 Million 25.37%

% of portfolio

0.04%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$25.89 - $29.73 $349,773 - $401,652	13,510 Added 30.06%	58,448 $1.62 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $449,880 - $584,344	-17,217 Reduced 27.7%	44,938 $1.29 Million
Q3 2023 Oct 30, 2023	BUY	$32.09 - $37.51 $7,669 - $8,964	239 Added 0.39%	62,155 $2.06 Million
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $468,512 - $542,058	12,971 Added 26.5%	61,916 $2.27 Million
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $218,496 - $284,450	5,547 Added 12.78%	48,945 $2 Million

Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $193,469 - $252,553	4,634 Added 11.95%	43,398 $2.22 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $176,484 - $215,442	-4,033 Reduced 9.42%	38,764 $1.7 Million
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $499,453 - $592,194	10,734 Added 33.48%	42,797 $2.24 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $216,123 - $267,803	4,724 Added 17.28%	32,063 $1.66 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $24,254 - $35,953	587 Added 2.19%	27,339 $1.61 Million
Q3 2021 Nov 16, 2021	BUY	$39.25 - $50.42 $94,200 - $121,008	2,400 Added 9.86%	26,752 $1.15 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $25,101 - $28,435	699 Added 2.96%	24,352 $954,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $56,263 - $63,453	-1,680 Reduced 6.63%	23,653 $857,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $847,895 - $1.08 Million	25,333 New	25,333 $933,000
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $735,361 - $862,747	-23,161 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $28,192 - $34,201	936 Added 4.21%	23,161 $757,000
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $600,741 - $858,329	22,225 New	22,225 $725,000
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $621,891 - $705,767	-18,891 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $81,679 - $105,914	2,514 Added 15.35%	18,891 $679,000
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $22,816 - $25,617	617 Added 3.91%	16,377 $709,000
Q1 2019 May 16, 2019	BUY	$37.5 - $41.2 $591,000 - $649,312	15,760 New	15,760 $669,000
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $1.98 Million - $2.12 Million	-60,172 Closed	0 $0
Q1 2018 May 22, 2018	SELL	$31.91 - $37.02 $45.2 Million - $52.4 Million	-1,415,910 Reduced 95.92%	60,172 $1.48 Million
Q1 2018 May 21, 2018	BUY	$31.91 - $37.02 $45.6 Million - $52.9 Million	1,429,293 Added 3054.76%	1,476,082 $1.48 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $1.56 Million - $1.65 Million	46,789	46,789 $1.72 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.

Account

Summit Trail Advisors, LLC Pfizer Inc Transaction History